2.07 USD
-0.12 (-5.48%)
2.03 USD
-0.04 (-1.93%)
ChartMill assigns a Buy % Consensus number of 84% to MRKR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.8. This target is 325% above the current price.
MRKR was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MRKR.
In the previous month the buy percentage consensus was at a similar level.
MRKR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-01 | WBB Securities | Reiterate | Strong Buy -> Strong Buy |
| 2025-03-05 | Canaccord Genuity | Initiate | Buy |
| 2024-10-21 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2024-04-30 | Ladenburg Thalmann | Initiate | Buy |
| 2022-02-17 | Roth Capital | Downgrade | Buy -> Neutral |
| 2021-03-25 | Piper Sandler | Initiate | Overweight |
| 2021-03-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-18 | Cantor Fitzgerald | Initiate | Overweight |
MARKER THERAPEUTICS INC / MRKR FAQ
What is the price target for MRKR stock?
9 analysts have analysed MRKR and the average price target is 8.8 USD. This implies a price increase of 325% is expected in the next year compared to the current price of 2.07.
How do analysts rate MARKER THERAPEUTICS INC (MRKR)?
The consensus rating for MARKER THERAPEUTICS INC (MRKR) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.